Novo Nordisk A/s
At Novo Nordisk, we are driving change to defeat diabetes and other serious chronic conditions. Diabetes poses one of todayÍs biggest global health challenges. We work for a future where fewer people get diabetes, everyone with diabetes is diagnosed, and everyone who is diagnosed receives adequate treatment and can live a life with as few limitations as possible. Since the company was founded in Denmark more than 90 years ago, we have been changing diabetes. This heritage has given us experience and capabilities that also enable us to help people defeat other serious chronic conditions: haemophilia, growth disorders and obesity. Our ambition is to take the lead in each of these areas, driving change with an unfailing belief that it can be done. This page isnÍt intended for discussions about products. As such, postings or comments that contain product discussions may be removed. This page is for discussions about Novo Nordisk and its subsidiaries and the initiatives and projects we are involved in. While we welcome everyone to make comments, we reserve the right to remove those that are off-topic, abusive or intended to spam. Any questions specific to products should be made to your healthcare professional. If you wish to file an adverse drug reaction please contact Novo NordiskÍs office in the country you live in: http://novonordisk.com/about_us/global_offices/global_offices.asp. For other customer complaints please contact us here: http://novonordisk.com/about_us/contact_us/contact_us.asp Please keep in mind that Novo Nordisk A/S and its subsidiaries work within a highly regulated industries. Therefore, comments that pertain to legal matters or regulatory issues may be removed. Comments contained on this site come from members of the public, and do not necessarily reflect the views of Novo Nordisk A/S. Novo Nordisk A/S does not endorse or approve any content added by other Linkedin users. Learn more about our community guidelines here http://bit.ly/NN-disclaimer
Pharmaceuticals
> 10,000
Bagsvaerd, Denmark
About

At Novo Nordisk, we are driving change to defeat diabetes and other serious chronic conditions. Diabetes poses one of todayÍs biggest global health challenges. We work for a future where fewer people get diabetes, everyone with diabetes is diagnosed, and everyone who is diagnosed receives adequate treatment and can live a life with as few limitations as possible.

Since the company was founded in Denmark more than 90 years ago, we have been changing diabetes. This heritage has given us experience and capabilities that also enable us to help people defeat other serious chronic conditions: haemophilia, growth disorders and obesity. Our ambition is to take the lead in each of these areas, driving change with an unfailing belief that it can be done.

This page isnÍt intended for discussions about products. As such, postings or comments that contain product discussions may be removed. This page is for discussions about Novo Nordisk and its subsidiaries and the initiatives and projects we are involved in. While we welcome everyone to make comments, we reserve the right to remove those that are off-topic, abusive or intended to spam.

Any questions specific to products should be made to your healthcare professional. If you wish to file an adverse drug reaction please contact Novo NordiskÍs office in the country you live in: http://novonordisk.com/about_us/global_offices/global_offices.asp.

For other customer complaints please contact us here: http://novonordisk.com/about_us/contact_us/contact_us.asp

Please keep in mind that Novo Nordisk A/S and its subsidiaries work within a highly regulated industries. Therefore, comments that pertain to legal matters or regulatory issues may be removed.

Comments contained on this site come from members of the public, and do not necessarily reflect the views of Novo Nordisk A/S. Novo Nordisk A/S does not endorse or approve any content added by other Linkedin users.

Learn more about our community guidelines here http://bit.ly/NN-disclaimer

Site Traffic
  • 168503 Global Rank
  • 3882
    Denmark
  • 292 K Estimated Visits
Traffic Sources
  • Direct
    36.50%
  • Search
    32.96%
  • Social
    21.07%
  • Referrals
    8.45%
  • Mail
    1.00%
  • Display
    0.02%
Geography Breakdown
Powered by
Alexa Traffic Data
Global Rank 76,024
102,661
India Rank 26,209
10,392
India Page Views 25.1%
2.9%
Top Countries
Top Search Keywords
  • Biotechnology and Pharmaceuticals
  • Pharmaceuticals
Mobile App Data
MixRank is the most comprehensive database of mobile apps, developers, SDKs, technologies, services, and integrations. Learn more.
  • 10 SDKs
  • 3.0 Avg. Rating
  • 5 Total reviews
  • App Url: https://itunes.apple.com/app/novo-nordisk-1/id409407936
  • App Support: http://www.CoagsUncomplicated.com
  • Genre: Medical
  • Bundle ID: com.novonordisk-us.novoseven
  • App Size: 25.1 M
  • Version: 2.5.0
  • Release Date: December 18th, 2010
  • Update Date: November 28th, 2017

Description:

Download the one-of-a-kind resource that can provide you with instant access to comprehensive bleeding disorder information anytime, anywhere. Coags Uncomplicated™ has helped put an expert bleeding disorder reference at the fingertips of >7000 healthcare professionals across >10 specialties ranging from hematology and oncology to critical care and pediatrics.

In a survey of 262 healthcare professionals who use Coags UncomplicatedTM:
-The app was rated 4.25 out of 5
-89% have used it as a reference in clinical decision making or case management
-Nearly 9 in 10 would recommend it to colleagues

Comprising lab patterns and thorough disease descriptions for dozens of bleeding disorders and blood tests, Coags UncomplicatedTM includes valuable tools to aid you in the identification of bleeding disorders. Features of the app include:
-Lab Value Analyzer: Enter lab results to receive a list of possible diagnoses to consider from a database of >60 bleeding disorders
-Diagnostic Algorithm: Begin with prothrombin time and activated partial thromboplastin time results, then narrow your differential diagnosis
-Neonatal Module: Receive specialized assistance to help you evaluate bleeding disorders in the neonatal population, where normal values are age sensitive
-Face a Case: Test your clinical skills with 5 case studies across a variety of bleeding disorders, both adult and pediatric
-Coag Challenge: Answer challenging bleeding disorder questions in an educational, fast-paced quiz

Designed for professionals by professionals, Coags UncomplicatedTM was developed by Novo Nordisk in partnership with key thought leaders in hematology and coagulation assays:
-Craig M. Kessler, MD, MACP, Professor of Medicine and Pathology, Director of the Coagulation Laboratory, Georgetown University Hospital, Lombardi Comprehensive Cancer Center, Washington, DC
-Ellinor I. Peerschke, PhD, FAHA, Vice Chair, Department of Laboratory Medicine, Head of Hematology and Coagulation Laboratory Services, Memorial Sloan-Kettering Cancer Center, New York, NY
-Meera B. Chitlur, MD, Associate Professor of Pediatrics, Wayne State University School of Medicine, Staff Physician, Division of Hematology/Oncology, Children’s Hospital of Michigan, Detroit, MI
-Roshni Kulkarni, MD, Professor of Pediatrics and Human Development, Director of Pediatric and Adolescent Hematology/Oncology, College of Human Medicine, Michigan State University, East Lansing, MI

Get Coags UncomplicatedTM today and discover the in-depth clinical information that thousands of healthcare professionals are already using.

Coags Uncomplicated™ is a reference tool. Clinical correlation and consultation with a hematologist are advised to ensure an accurate diagnosis.

Novo Nordisk Inc., 800 Scudders Mill Road, Plainsboro, New Jersey 08536 U.S.A.

Coags Uncomplicated™ is a trademark of Novo Nordisk Health Care AG.
Novo Nordisk is a registered trademark of Novo Nordisk A/S.
© 2013 Novo Nordisk All rights reserved. 1013-00018569-1 November 2013

Sort by

lilgreyk64

Nov 30, 2012

Collecting personal data

I agree with another reviewer.. Why does this app request collection of personal data ? None of my other medical apps request this ! I don't need more spam , so no thanks ....

Bikingsuz

Aug 08, 2012

Usual application conflicts

This could potentially be a good app, but be forewarned, that if you load it on your ipad, you will have problems (as usual) using it on your iPhone. (yawn) Also surprised to see under registering and under user ID's (required to use this "free" app), lots of physicians but no lab. Who do you think runs these coag tests?

Boricuagirl956

Apr 22, 2012

Excellent!!!

Very valuable information and very useful when doubts.. Excellent guide but I wish they could include more factors % options to consider other diagnosis like AT-3% and also it should include suggestive treatment. Excellent app

Gee2G

Jan 17, 2011

Coags

This ap is not available for use until extensive personal information is registered. It would appear to be essentially a front to collect advertising data. The pharmaceutical sponsor should release it without the associated strings.

Dean0912

Jan 16, 2011

Pharm

This is most comprehensive resource I have seen on diagnosing coag disorders. The algorithms are great teaching tools!!
Core Graphics
The Core Graphics framework is based on the Quartz advanced drawing engine. It provides low-level, lightweight 2D rendering with unmatched output fidelity. You use this framework to handle path-based drawing, transformations, color management, offscreen rendering, patterns, gradients and shadings, image data management, image creation, and image masking, as well as PDF document creation, display, and parsing.
Launch Services
macOS Launch Services is an API that enables a running app to open other apps or their document files, similar to the Finder or the Dock.Launch Services eliminates apps having to query the Finder to open an app, document, or URL for them. The macOS Finder itself uses Launch Services to perform such tasks. Because the Finder performs no additional processing beyond calling Launch Services, any client using Launch Services for these purposes behaves identically to the Finder.
Security Framework
Secure the data your app manages. Protect information and control access to your app.
System Configuration F...
This collection of documents describes the programming interfaces of the System Configuration framework. The System Configuration framework provides functions that determine the reachability of target hosts in both a synchronous and an asynchronous manner. It also provides error detection facilities.
CFNetwork
Access network services and handle changes in network configurations. Build on abstractions of network protocols to simplify tasks such as working with BSD sockets, administering HTTP and FTP servers, and managing Bonjour services.
Core Foundation Framework
Core Foundation is a framework that provides fundamental software services useful to application services, application environments, and to applications themselves. Core Foundation also provides abstractions for common data types, facilitates internationalization with Unicode string storage, and offers a suite of utilities such as plug-in support, XML property lists, URL resource access, and preferences.
Foundation Framework
The Foundation framework provides a base layer of functionality for apps and frameworks, including data storage and persistence, text processing, date and time calculations, sorting and filtering, and networking. The classes, protocols, and data types defined by Foundation are used throughout the macOS, iOS, watchOS, and tvOS SDKs.
MobileCoreServices
Use uniform type identifier (UTI) information to create and manipulate data that can be exchanged between your app and other apps and services using MobileCoreServices.
Quartz Core Framework
Allow users to browse, edit, and save images, using slideshows and Core Image filters.The Quartz Composer API supports processing and rendering graphical data and allows developers to create custom patches for the Quartz Composer developer tool. ImageKit provides user interface support for browsing, editing, and saving images, showing slideshows, and browsing and previewing Core Image filters. PDFKit is a technology that allows applications to display and manipulate PDF documents.
UIKit
The UIKit framework (UIKit.framework) provides the crucial infrastructure needed to construct and manage iOS apps. This framework provides the window and view architecture needed to manage an app’s user interface, the event handling infrastructure needed to respond to user input, and the app model needed to drive the main run loop and interact with the system.
Data sourced from MixRank, the most comprehensive database of mobile apps, developers, SDKs, technologies, services, and integrations. Learn More.
Ad Intelligence
  • Standard
    93.65%
  • Direct
    6.35%
Ads Seen Recently
59
Longest Running Ad
Novo Nordisk A::S
Device
Desktop
Dimensions
728x90
Novo Nordisk A::S
Device
Desktop
Dimensions
300x600
Novo Nordisk A::S
Device
Desktop
Dimensions
300x600
Novo Nordisk A::S
Device
Desktop
Dimensions
728x90
Novo Nordisk A::S
Device
Desktop
Dimensions
160x600
Novo Nordisk A::S
Device
Desktop
Dimensions
160x600
Novo Nordisk A::S
Novo Nordisk A/s receives up to 0.39M pageviews per day, in countries such as India, Egypt, Thailand, Bangladesh, Azerbaijan, Pakistan, Cameroon, United States, United Kingdom, Denmark, Canada.

They are headquartered at Bagsvaerd, Denmark, and have 2 advertising & marketing contacts listed on Kochava. Novo Nordisk A/s works with Advertising technology companies such as Videology, The Trade Desk, Chango, Dstillery, Turn, Neustar AdAdvisor, AOL-Time Warner Online Advertising, Media Innovation Group, Atlas, DoubleClick.Net, AppNexus, BlueKai, Resonate Insights, DemDex, Facebook Exchange FBX, AppNexus Segment Pixel, Yahoo Small Business, Facebook Custom Audiences, LinkedIn Ads, Bizo, Google Remarketing, Twitter Ads, DoubleClick Bid Manager, Adobe Audience Manager.